Evidence map›Paper›PMID 39092886›Full record

ArticleAndrology2025

Mild coronavirus disease 2019: Results of a multicentric prospective study on severe acute respiratory syndrome coronavirus 2 presence in semen fractions and cells and its effects on semen parameters.

Louis Bujan, Gabriela Mendeluk, Dominique Mahé, Marie-Astrid Llabador, Celia Bettiol, Ingrid Plotton, Jean-Michel Mansuy, Pierre Delobel, Myriam Daudin, Nathalie Moinard and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Louis BujanInstitut National de la Santé et de la Recherche Médicale (Inserm), Développement Embryonnaire, Fertilité, Environnement (DEFE, INSERM 1203) and CECOS, Service de Médecine de la Reproduction, Hôpital Paule de Viguier, CHU Toulouse, Toulouse, France.ORCID 0000-0003-1540-0536
Gabriela MendelukLaboratory of Male Fertility, Buenos Aires University Clinical Hospital "José de San Martín", INFIBIOC, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Dominique MahéPhysiologie et Physiopathologie du Tractus Urogénital (Urgent), Université de Rennes, INSERM, Institut de Recherche en Santé, Environnement et Travail (Irset), Rennes, France.
Marie-Astrid LlabadorService de Biologie de la Reproduction, Hôpital Bichat, AP-HP Nord, Paris, France.
Celia BettiolInstitut National de la Santé et de la Recherche Médicale (Inserm), Développement Embryonnaire, Fertilité, Environnement (DEFE, INSERM 1203) and CECOS, Service de Médecine de la Reproduction, Hôpital Paule de Viguier, CHU Toulouse, Toulouse, France.
Ingrid PlottonLaboratoire de Biochimie et Biologie Moléculaire, Hormonologie et Endocrinologie Moléculaire, Hospices Civils de Lyon, Bron, France.
Jean-Michel MansuyLaboratoire de Virologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
Pierre DelobelService des Maladies Infectieuses et Tropicales, Hôpital Purpan, CHU Toulouse, Toulouse, France.
Myriam DaudinInstitut National de la Santé et de la Recherche Médicale (Inserm), Développement Embryonnaire, Fertilité, Environnement (DEFE, INSERM 1203) and CECOS, Service de Médecine de la Reproduction, Hôpital Paule de Viguier, CHU Toulouse, Toulouse, France.
Nathalie MoinardInstitut National de la Santé et de la Recherche Médicale (Inserm), Développement Embryonnaire, Fertilité, Environnement (DEFE, INSERM 1203) and CECOS, Service de Médecine de la Reproduction, Hôpital Paule de Viguier, CHU Toulouse, Toulouse, France.
Julia AriagnoLaboratory of Male Fertility, Buenos Aires University Clinical Hospital "José de San Martín", INFIBIOC, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0002-3436-6022
Patricia ChenloLaboratory of Male Fertility, Buenos Aires University Clinical Hospital "José de San Martín", INFIBIOC, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Muriel AlvarezService des Maladies Infectieuses et Tropicales, Hôpital Purpan, CHU Toulouse, Toulouse, France.
Nathalie Dejucq-RainsfordPhysiologie et Physiopathologie du Tractus Urogénital (Urgent), Université de Rennes, INSERM, Institut de Recherche en Santé, Environnement et Travail (Irset), Rennes, France.
Christophe PasquierLaboratoire de Virologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.

Funding

Merck Sharp and Dohme France
6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2, the virus responsible for coronavirus disease 2019, affects multiple organs. The virus enters cells through angiotensin-converting enzyme-2 and host factors present in genital organs, leading to concern over virus shedding in semen and reproductive function.

objectivesTo investigate severe acute respiratory syndrome coronavirus 2 in semen from patients with a mild infection, identify the seminal infected cells, and explore the effect of the infection on sex hormones and semen parameters. MATERIALS AND

methodsProspective study of 54 men with mild severe acute respiratory syndrome coronavirus 2 infection. Semen was collected at 7, 15, 30, 60, 90, 180, and 365 days after symptom onset, and severe acute respiratory syndrome coronavirus 2 RNA was measured in serum, saliva, urine, and semen. The presence of infectious severe acute respiratory syndrome coronavirus 2 in semen was assessed using Vero cell culture. Infected semen cells were identified using immunofluorescence against severe acute respiratory syndrome coronavirus 2 nucleoprotein antigen and cell markers. Semen characteristics as well as testosterone, inhibin B, luteinizing hormone, and follicle-stimulating hormone levels were determined.

results11% of patients had at least one severe acute respiratory syndrome coronavirus 2 RNA-positive semen. One patient had viral semen shedding up to day 90 after infection onset, with replication-competent virus isolated from semen and 40% cell fraction at day 7. After sperm preparation, 90% fraction was severe acute respiratory syndrome coronavirus 2 RNA-positive at days 7 and 15. The swim-up fraction was positive only on day 7. In semen, nucleoprotein antigen was detected mainly in exfoliated epithelial cells and less frequently in Sertoli cells. Sperm count and motile sperm count were lower at day 30 than at day 7. Round cells in semen were increased during the acute phase. At days 7 and 15, sperm count and motile sperm count were lower in severe acute respiratory syndrome coronavirus 2 RNA-positive semen compared with negative semen, while semen volume and follicle-stimulating hormone levels were increased. Long-term follow-up shows no evidence of a detrimental effect on hormonal or semen characteristics. DISCUSSION AND

conclusion11% of patients with mild coronavirus disease 2019 who were not hospitalized had severe acute respiratory syndrome coronavirus 2 excretions in semen, which persisted for up to 90 days in one patient. No germ cells appeared infected by the virus, but the detection of nucleoprotein antigen-positive epithelial semen cells and Sertoli cells suggests genital tract infection. Albeit infrequent, semen may contain the replication-competent virus during the acute phase with potential risk of severe acute respiratory syndrome coronavirus 2 transmissions during sexual contact and assisted reproduction procedures. The effect of mild coronavirus disease 2019 on spermatogenesis and reproductive hormones was moderate and reversible.

Indexed as

COVID-19SARS-CoV-2SemenAdultAnimalsChlorocebus aethiopsFollicle Stimulating HormoneHumansInhibinsLuteinizing HormoneMaleMiddle AgedProspective StudiesRNA, ViralSemen AnalysisTestosteroneFollicle Stimulating Hormoneinhibin BInhibinsLuteinizing HormoneRNA, ViralTestosteroneCOVID‐19male genital tractmale reproductive functionreproductive biologySARS‐CoV‐2semenseminal cellssexual transmission risksheddingvirus semen

Identifiers

PMID39092886
PMCPMC11867923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.